| Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ... Clinical infectious diseases 62 (4), e1-e50, 2016 | 3951 | 2016 |
| Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, D Andes, DK Benjamin Jr, TF Calandra, ... Clinical infectious diseases: an official publication of the Infectious …, 2009 | 3871 | 2009 |
| Guidelines for treatment of candidiasis PG Pappas, JH Rex, JD Sobel, SG Filler, WE Dismukes, TJ Walsh, ... Clinical infectious diseases 38 (2), 161-189, 2004 | 2017 | 2004 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1854 | 2020 |
| Invasive candidiasis PG Pappas, MS Lionakis, MC Arendrup, L Ostrosky-Zeichner, BJ Kullberg Nature Reviews Disease Primers 4 (1), 1-20, 2018 | 1199 | 2018 |
| Multicenter clinical evaluation of the (1→ 3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans L Ostrosky-Zeichner, BD Alexander, DH Kett, J Vazquez, PG Pappas, ... Clinical Infectious Diseases 41 (5), 654-659, 2005 | 923 | 2005 |
| β-d-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia … Z Odabasi, G Mattiuzzi, E Estey, H Kantarjian, F Saeki, RJ Ridge, ... Clinical Infectious Diseases 39 (2), 199-205, 2004 | 912 | 2004 |
| Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial ER Kuse, P Chetchotisakd, CA da Cunha, M Ruhnke, C Barrios, ... The Lancet 369 (9572), 1519-1527, 2007 | 859 | 2007 |
| Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis PG Pappas, CMF Rotstein, RF Betts, M Nucci, D Talwar, JJ De Waele, ... Clinical infectious diseases 45 (7), 883-893, 2007 | 754 | 2007 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ... The Lancet Infectious Diseases 21 (6), e149-e162, 2021 | 730 | 2021 |
| Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ... The Lancet infectious diseases 16 (7), 828-837, 2016 | 663 | 2016 |
| Combination antifungal therapy MD Johnson, C MacDougall, L Ostrosky-Zeichner, JR Perfect, JH Rex Antimicrobial agents and chemotherapy 48 (3), 693-715, 2004 | 648 | 2004 |
| Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States L Ostrosky-Zeichner, JH Rex, PG Pappas, RJ Hamill, RA Larsen, ... Antimicrobial agents and chemotherapy 47 (10), 3149-3154, 2003 | 635 | 2003 |
| An insight into the antifungal pipeline: selected new molecules and beyond L Ostrosky-Zeichner, A Casadevall, JN Galgiani, FC Odds, JH Rex Nature reviews Drug discovery 9 (9), 719-727, 2010 | 513 | 2010 |
| Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of … BH Segal, R Herbrecht, DA Stevens, L Ostrosky-Zeichner, J Sobel, ... Clinical infectious diseases 47 (5), 674-683, 2008 | 478 | 2008 |
| Amphotericin B: time for a new" gold standard" L Ostrosky-Zeichner, KA Marr, JH Rex, SH Cohen Clinical Infectious Diseases, 415-425, 2003 | 473 | 2003 |
| Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting L Ostrosky-Zeichner, C Sable, J Sobel, BD Alexander, G Donowitz, V Kan, ... European Journal of Clinical Microbiology & Infectious Diseases 26, 271-276, 2007 | 464 | 2007 |
| T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial E Mylonakis, CJ Clancy, L Ostrosky-Zeichner, KW Garey, GJ Alangaden, ... Clinical Infectious Diseases 60 (6), 892-899, 2015 | 438 | 2015 |
| Invasive candidiasis in the intensive care unit L Ostrosky-Zeichner, PG Pappas Critical care medicine 34 (3), 857-863, 2006 | 397 | 2006 |
| Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ... Clinical Infectious Diseases 62 (4), 409-417, 2016 | 348 | 2016 |
peter pappasUniversity of Alabama at BirminghamVerified email at uab.edu
